AMB-CHMINACA

Chemical compound From Wikipedia, the free encyclopedia

AMB-CHMINACA or MMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid[1] that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.[2][3][4]

Legal status
Quick facts Legal status, Identifiers ...
AMB-CHMINACA
Legal status
Legal status
Identifiers
  • methyl (2S)-2-{[1-(cyclohexylmethyl)indazole-3-carbonyl]amino}-3-methylbutanoate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H29N3O3
Molar mass371.481 g·mol−1
3D model (JSmol)
  • COC([C@H](C(C)C)NC(C1=NN(C2=C1C=CC=C2)CC3CCCCC3)=O)=O
  • InChI=1S/C21H29N3O3/c1-14(2)18(21(26)27-3)22-20(25)19-16-11-7-8-12-17(16)24(23-19)13-15-9-5-4-6-10-15/h7-8,11-12,14-15,18H,4-6,9-10,13H2,1-3H3,(H,22,25)/t18-/m0/s1
  • Key:CRGGXDSTBHQLKJ-SFHVURJKSA-N
Close

AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[5]

Sweden's public health agency classified AMB-CHMINACA as a narcotic substance, on January 18, 2019.[6]

See also

References

Related Articles

Wikiwand AI